323 related articles for article (PubMed ID: 9361089)
1. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
Leckström A; Ziv E; Shafrir E; Westermark P
Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
[TBL] [Abstract][Full Text] [Related]
2. Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levels.
Duhault J; Boulanger M; Espinal J; Marquié G; Petkov P; Donev S; Jablenska R; Popov A
Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):535-40. PubMed ID: 8061570
[TBL] [Abstract][Full Text] [Related]
3. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil.
Shafrir E; Spielman S; Nachliel I; Khamaisi M; Bar-On H; Ziv E
Diabetes Metab Res Rev; 2001; 17(1):55-66. PubMed ID: 11241892
[TBL] [Abstract][Full Text] [Related]
4. Regulation of muscle malonyl-CoA levels in the nutritionally insulin-resistant desert gerbil, Psammomys obesus.
Shafrir E; Ziv E; Saha AK; Ruderman NB
Diabetes Metab Res Rev; 2002; 18(3):217-23. PubMed ID: 12112940
[TBL] [Abstract][Full Text] [Related]
5. Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue.
Uçkaya G; Delagrange P; Chavanieu A; Grassy G; Berthault MF; Ktorza A; Cerasi E; Leibowitz G; Kaiser N
J Endocrinol; 2005 Mar; 184(3):505-13. PubMed ID: 15749809
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia and hyperinsulinemia in the sand rat (Psammomys obesus) with positive or negative energy balance.
Adler JH
Isr J Med Sci; 1982 Jan; 18(1):187-91. PubMed ID: 7040298
[TBL] [Abstract][Full Text] [Related]
7. Glucose-dependent and -independent electrical activity in islets of Langerhans of Psammomys obesus, an animal model of nutritionally induced obesity and diabetes.
Zimliki CL; Chenault VM; Mears D
Gen Comp Endocrinol; 2009 Apr; 161(2):193-201. PubMed ID: 19167400
[TBL] [Abstract][Full Text] [Related]
8. Prevention of nutritionally induced diabetes by rosiglitazone in the gerbil Psammomys obesus.
Hefetz S; Ziv E; Jörns A; Lenzen S; Shafrir E
Diabetes Metab Res Rev; 2006; 22(2):139-45. PubMed ID: 16088969
[TBL] [Abstract][Full Text] [Related]
9. Vanadyl sulfate ameliorates insulin resistance and restores plasma dehydroepiandrosterone-sulfate levels in fructose-fed, insulin-resistant rats.
Harati M; Ani M
Clin Biochem; 2004 Aug; 37(8):694-7. PubMed ID: 15302613
[TBL] [Abstract][Full Text] [Related]
10. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
N Engl J Med; 1989 Aug; 321(8):513-8. PubMed ID: 2668761
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
13. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
14. Prevention of insulin resistance and beta-cell loss by abrogating PKCepsilon-induced serine phosphorylation of muscle IRS-1 in Psammomys obesus.
Mack E; Ziv E; Reuveni H; Kalman R; Niv MY; Jörns A; Lenzen S; Shafrir E
Diabetes Metab Res Rev; 2008 Oct; 24(7):577-84. PubMed ID: 18613220
[TBL] [Abstract][Full Text] [Related]
15. Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of severely insulin-deficient diabetes mellitus with atrophied exocrine pancreas.
Sugawara K; Kobayashi T; Nakanishi K; Kajio H; Ohkubo M; Sugimoto T; Murase T; Itoh T; Hara M; Kosaka K
Pancreas; 1993 May; 8(3):312-5. PubMed ID: 8483872
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
17. Physical exercise increases the expression of TNFalpha and GLUT 1 in muscle tissue of diabetes prone Psammomys obesus.
Heled Y; Dror Y; Moran DS; Rosenzweig T; Sampson SR; Epstein Y; Meyerovitch J
Life Sci; 2005 Oct; 77(23):2977-85. PubMed ID: 16043194
[TBL] [Abstract][Full Text] [Related]
18. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
Westermark P; Andersson A; Westermark GT
Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
[TBL] [Abstract][Full Text] [Related]
19. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model.
Höppener JW; Oosterwijk C; Nieuwenhuis MG; Posthuma G; Thijssen JH; Vroom TM; Ahrén B; Lips CJ
Diabetologia; 1999 Apr; 42(4):427-34. PubMed ID: 10230646
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.
Phillips JW; Barringhaus KG; Sanders JM; Yang Z; Chen M; Hesselbacher S; Czarnik AC; Ley K; Nadler J; Sarembock IJ
Circulation; 2003 Oct; 108(16):1994-9. PubMed ID: 14517165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
